BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26599808)

  • 1. Folate Receptor α Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma.
    Driver BR; Barrios R; Ge Y; Haque A; Tacha D; Cagle PT
    Arch Pathol Lab Med; 2016 Jul; 140(7):682-5. PubMed ID: 26599808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents.
    Cagle PT; Zhai QJ; Murphy L; Low PS
    Arch Pathol Lab Med; 2013 Feb; 137(2):241-4. PubMed ID: 22984810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
    Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
    J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of folate receptor alpha immunohistochemistry in cytology specimens of metastatic breast carcinoma, metastatic serous carcinoma of Müllerian origin, and primary lung adenocarcinoma.
    Sheikh UN; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 May; 44(5):369-76. PubMed ID: 26875861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.
    Driver BR; Miller RA; Miller T; Deavers M; Gorman B; Mody D; Ge Y; Barrios R; Bernicker E; Kim M; Cagle PT
    Arch Pathol Lab Med; 2017 Nov; 141(11):1529-1532. PubMed ID: 28829153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of folate receptor-α (FRA) in gynecologic malignancies and its relationship to the tumor type.
    O'Shannessy DJ; Somers EB; Smale R; Fu YS
    Int J Gynecol Pathol; 2013 May; 32(3):258-68. PubMed ID: 23518909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate Receptor Alpha Expression in Platinum Resistant/Refractory Ovarian Carcinomas and Primary Endocervical Adenocarcinomas.
    Rubinsak LA; Cohen C; Khanna N; Horowitz IR; Hanley KZ
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):567-572. PubMed ID: 27941566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver agreement and assay reproducibility of folate receptor α expression in lung adenocarcinoma: a prognostic marker and potential therapeutic target.
    Bremer RE; Scoggin TS; Somers EB; O'Shannessy DJ; Tacha DE
    Arch Pathol Lab Med; 2013 Dec; 137(12):1747-52. PubMed ID: 23570254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate receptor α associated with triple-negative breast cancer and poor prognosis.
    Zhang Z; Wang J; Tacha DE; Li P; Bremer RE; Chen H; Wei B; Xiao X; Da J; Skinner K; Hicks DG; Bu H; Tang P
    Arch Pathol Lab Med; 2014 Jul; 138(7):890-5. PubMed ID: 24028341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.
    O'Shannessy DJ; Yu G; Smale R; Fu YS; Singhal S; Thiel RP; Somers EB; Vachani A
    Oncotarget; 2012 Apr; 3(4):414-425. PubMed ID: 22547449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA; Sharma R; Illei PB
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
    Zhao SJ; Wu N; Zheng R; Liu Y; Zhang WJ; Liang Y; Zhang H; Li XM
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of folate receptor-α and epidermal growth factor receptor expression in pemetrexed-treated non-small-cell lung cancer patients.
    Christoph DC; Reyna-Asuncion B; Hassan B; Tran C; Maltzman JD; O'Shannessy DJ; Gauler TC; Wohlschlaeger J; Schuler M; Eberhardt WE; Hirsch FR
    Clin Lung Cancer; 2014 Sep; 15(5):320-30.e1-3. PubMed ID: 24993594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple Negative Breast Cancer: Expression of Folate Receptor Alpha in Indian population.
    Gajaria P; Kadu V; Patil A; Desai S; Shet T
    Ann Diagn Pathol; 2020 Dec; 49():151598. PubMed ID: 32919338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
    Sheikh UN; Cohen C; Siddiqui MT
    Acta Cytol; 2015; 59(4):298-304. PubMed ID: 26413911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of annexin I in different histological types of carcinomas].
    Xue LY; Teng LH; Zou SM; Ren LQ; Zheng S; Luo W; Bi R; Lü N
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):444-8. PubMed ID: 17974280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMP3 expression is correlated with histologic grade of lung adenocarcinoma.
    Findeis-Hosey JJ; Yang Q; Spaulding BO; Wang HL; Xu H
    Hum Pathol; 2010 Apr; 41(4):477-84. PubMed ID: 20004948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
    Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.
    Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH
    Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.